Please use this identifier to cite or link to this item:
Title: Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function.
Issue Date: 2016
Citation: BMJ Open Gastroenterol.2016;(3)1:e000104
Abstract: Non-selective β-blockers (NSBBs) are widely prescribed in patients with cirrhosis for primary and secondary prophylaxis of bleeding oesophageal varices. Furthermore, it has been suggested that the clinical benefits of NSBBs may extend beyond their haemodynamic effects. Recently, a potentially harmful effect has been described in patients with refractory ascites or spontaneous bacterial peritonitis.
PMID: 28074149
Rights: openAccess
ISSN: 2054-4774
Appears in Collections:Hospitales > H. U. Fundación Alcorcón > Artículos

Files in This Item:
File Description SizeFormat 
PMC5174812.pdf1.13 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.